BIO IP & Diagnostics Symposium (IPDx) Keynote Session

Dr. Patrik Frei was the keynote speaker at BIO IP & Diagnostics Symposium (IPDx) on 29th of September 2017. During the session, the Venture Valuation CEO discussed the valuation of biotechnology companies and products and its link to IP. He gave a short introduction to risk-adjusted net present value calculations, the main value drivers and a looked at how these can drive deal terms and negotiations.

Download the notes.